Q4 2025 Earnings: Glaukos and Targa Lead Mid-Cap Growth Amid Sector Divergence

The conclusion of the Q4 2025 earnings season has highlighted a significant divergence in performance across mid-cap sectors, with specialized healthcare and energy infrastructure firms demonstrating superior pricing power and volume growth. Glaukos Corporation (GKOS) and Targa Resources (TRGP) have emerged as the primary beneficiaries of long-term secular trends, while companies like Pool Corporation (POOL) and N-able (NABL) are navigating more complex macroeconomic headwinds related to consumer spending and IT budget consolidation.

Glaukos Corporation reported a transformative quarter, largely driven by the accelerated commercial adoption of iDose TR, its long-acting injectable for glaucoma. The company’s ability to transition from a device-centric model to a pharmaceutical-plus-device hybrid has significantly expanded its addressable market. Analysts noted that the reimbursement landscape for micro-invasive glaucoma surgery (MIGS) has stabilized, allowing Glaukos to capture market share from traditional topical drop therapies. This shift is not merely a product success but a strategic pivot that has improved the company’s recurring revenue profile, a key metric that investors are rewarding in the current high-interest-rate environment.

“

Glaukos Corporation reported a transformative quarter, largely driven by the accelerated commercial adoption of iDose TR, its long-acting injectable for glaucoma.

In the energy sector, Targa Resources continues to capitalize on the sustained production volumes in the Permian Basin. Its Q4 results underscored the critical nature of midstream infrastructure, with record natural gas liquid (NGL) pipeline volumes and fractionation throughput. Targa’s integrated model—moving molecules from the wellhead to the export terminal—has insulated it from commodity price volatility, focusing instead on fee-based earnings. The company’s capital expenditure on the Greenwood and Daytona expansion projects is beginning to yield high-margin returns, positioning it as a defensive powerhouse within the broader energy complex.

Conversely, the digital health and IT services sectors are showing signs of maturation and increased competition. Talkspace (TALK) has successfully navigated its transition toward a B2B-heavy model, securing significant contracts with major health payers and employers. However, while revenue growth remains steady, the cost of clinician acquisition and retention continues to weigh on net margins. Similarly, N-able (NABL) is benefiting from the ongoing need for cybersecurity among small and medium-sized enterprises (SMEs), but the sales cycle for its managed services platform has lengthened as IT directors scrutinize software-as-a-service (SaaS) expenditures more closely.